Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Molina Healthcare Insider Richard M. Schapiro Sells $159K of Stock
Richard M. Schapiro sold 782 shares of Molina Healthcare, Inc. at $203.94 a share, worth $159K in total on Nov 10, 2026. Shares held after the trade: 11,833 (-6.2%).
Paul Gu, CEO, bought 50,000 shares of Upstart Holdings, Inc. at $20.57 a share, worth $1.03M in total on Nov 11, 2026. Shares held after the trade: 180,000 (+38.5%).
Molina Healthcare CLO Jeff D. Barlow Sells $1.62M of Stock
Jeff D. Barlow, CLO, sold 8,000 shares of Molina Healthcare, Inc. at $203.07 a share, worth $1.62M in total on Nov 10, 2026. Shares held after the trade: 59,313 (-11.9%).
Jack in the Box Exec Chairman & Interim CEO Mark James King Sells $113K of Stock
Mark James King, Exec Chairman & Interim CEO, sold 7,977 shares of Jack in the Box Inc at $14.11 a share, worth $113K in total on Nov 13, 2026. Shares held after the trade: 161,288 (-4.7%).
Veradermics 10% Owner Longitude Capital Partners V LLC Sells $75.2M of Stock
Longitude Capital Partners V LLC, 10% Owner, sold 500,000 shares of Veradermics, Inc at $150.38 a share, worth $75.2M in total on Nov 11, 2026. Shares held after the trade: 1,803,474 (-12.2%).
Neonc Technologies Holdings CEO, President Amir F. Heshmatpour Buys $151K of Stock
Amir F. Heshmatpour, CEO, President, bought 30,000 shares of Neonc Technologies Holdings, Inc. at $5.02 a share, worth $151K in total on Nov 13, 2026. Shares held after the trade: 3,353,000 (+0.9%).
Sinclair COO & President of Local Media Robert Weisbord Sells $150K of Stock
Robert Weisbord, COO & President of Local Media, sold 10,000 shares of Sinclair, Inc. at $15.02 a share, worth $150K in total on Nov 11, 2026. Shares held after the trade: 289,408 (-3.3%).
Global Partners Insider Global GP LLC Buys $442K of Stock
Global GP LLC bought 10,000 shares of Global Partners LP at $43.79 to $44.56 a share (average $44.25) in 3 transactions, worth $442K in total between Nov 11, 2026 and Nov 13, 2026. Shares held after the trade: 181,584 (+1.4%).
Alset Inc. reported a net loss of $6.7 million for the nine months ended September 30, 2026, compared to a $16.4 million loss in the prior year period. Total revenue decreased slightly to $2.9 million, while the company recognized a significant $6.1 million gain from the deconsolidation of ESYN during the third quarter.
Perpetua Resources Corp. reported a significant increase in net loss to $225.3 million for the nine months ended September 30, 2026, primarily driven by a surge in exploration and pre-development expenses. The company's cash position decreased to $443.4 million as it continues to invest in the Stibnite Gold Project and awaits full project financing.
Bristow Group Insider Solus Alternative Asset Management LP Sells $2.98M of Stock
Solus Alternative Asset Management LP sold 73,600 shares of Bristow Group Inc. at $40.37 to $41.45 a share (average $40.44) in 4 transactions, worth $2.98M in total between Nov 10, 2026 and Nov 13, 2026. Shares held after the trade: 2,766,836 (-0.2%).
TPG Twin Brook Capital Income Fund reported total investment income of $359.4 million for the nine months ended September 30, 2026, up from $288.6 million in the prior year period. Net assets grew to $2.79 billion as of September 30, 2026, driven by $405.4 million in net capital share transactions and $187.9 million in net increase in net assets from operations.
Dragonfly Energy reported a net loss of $16.6 million for the nine months ended September 30, 2026, compared to a $24.9 million loss in the prior year period. Net sales decreased to $35.0 million from $45.6 million year-over-year, while the company's cash position significantly declined to $1.9 million as of September 30, 2026.
Syntec Optics reported net sales of $23.3 million for the nine months ended September 30, 2026, a 13.4% increase over the prior year. Despite the revenue growth, the company recorded a net loss of $395,046 for the period, though this was a significant improvement from the $1.45 million loss in 2025. The company's cash position strengthened substantially to $14.4 million following $23 million in gross proceeds from a common stock issuance.
MacroGenics, Inc. made available an updated corporate presentation on its website and as an exhibit to its 8-K filing. The presentation provides updated clinical program details and strategic priorities for the company's therapeutic candidates. The filing serves as a Regulation FD disclosure to ensure the updated information is available to the public and investors.
As of September 30, 2026, the Canary XRP ETF held $368.8 million in XRP, representing a net asset value of $15.79 per share. For the nine months ended September 30, 2026, the Trust reported a net decrease in net assets from operations of $60.5 million, primarily driven by $50.2 million in unrealized depreciation and $9.2 million in realized losses on its crypto currency investments.
Eightco Holdings Inc. reported a significant shift in its business model towards a Digital Asset Treasury Strategy, with total assets increasing to $446.3 million as of September 30, 2026, primarily driven by $205.4 million in digital assets and $82.6 million in stablecoins. However, the company experienced a sharp decline in revenues to $9.7 million for the nine months ended September 30, 2026, compared to $22.8 million in the prior year, resulting in an operating loss of $25.9 million.
Apollo Asset Backed Credit Company LLC reported total net assets of approximately $1.98 billion as of September 30, 2026, across its Series I and Series II interests. The company, an emerging growth company, saw its total assets grow to $2.52 billion from $1.89 billion at the end of 2025, driven primarily by an increase in investments at fair value.
Tempest Therapeutics reported third quarter 2026 financial results and provided a business update on its in vivo CAR-T pipeline, including the lead candidate TPST-4903. During the quarter, the company exercised its option for an exclusive license to Senlang's CD7-targeted platform and secured access to capital through a $50 million equity line of credit and a $2.5 million private placement.
“The third quarter marked a period of meaningful progress in the advancement of two next-generation in vivo CAR-T platforms with the potential to transform treatment across multiple diseases.”
Matt Angel, Ph.D., president and chief executive officer of Tempest
“We made important strides in expanding our pipeline and strengthening our position in the rapidly evolving in vivo CAR-T landscape through our strategic collaboration with Senlang by obtaining exclusive license rights to our clinical-stage BCMA/GPRC5D in vivo CAR-T candidate TPST-4903, while securing access to additional capital to support our development priorities.”
Matt Angel, Ph.D., president and chief executive officer of Tempest
BeyondSpring reported Q3 2026 financial results and highlighted that the FDA granted Fast Track designation for Plinabulin in combination with docetaxel for certain NSCLC patients. The company also completed a strategic transaction with Biolin to fund approximately half of the enrollment for the Phase 3 DUBLIN-4 trial.
Term
Q3 2026
“The FDA’s Fast Track designation underscores the significant unmet need for new treatment options for NSCLC patients without AGA and progressing after immune checkpoint inhibitor therapy, where docetaxel is still the standard of care.”
Min Qiu, Chief Executive Officer of BeyondSpring
“With an FDA-aligned Phase 3 design and a strategic transaction with Biolin to support approximately half of DUBLIN-4’s planned 442-patient enrollment, generating quality data from China, we remain focused on advancing the study toward its prespecified interim analysis at 221 progression-free survival events.”
Awaysis Capital, Inc. reported a net loss of $602,539 for the three months ended September 30, 2026, compared to a net loss of $651,548 in the prior year period. Revenue increased to $164,671 from $95,198, while the company continued to focus on its vacation rental and real estate development activities in Belize.
BCP Investment Corporation reported Q3 2026 financial results with total investment income of $13.9 million and net investment income of $4.6 million ($0.37 per share). The company also announced a definitive merger agreement to acquire Investcorp Credit Management BDC, Inc. (ICMB) at 90% of its closing NAV. Additionally, BCIC declared monthly base distributions of $0.09 per share for the first quarter of 2027.
FORUM MARKETS Inc. reported a net income of $7.85 million for the quarter ended September 30, 2026, a significant recovery from a $216.7 million loss in the prior year. The company transitioned its revenue model toward aircraft engine rentals while managing a substantial accumulated deficit of $673.3 million.
Mistras Group provided a status update on its pending acquisition by Athena Purchaser, LLC (an affiliate of H.I.G. Capital), disclosing that two lawsuits and multiple demand letters have been filed by stockholders alleging deficient disclosures in the merger proxy statement. The company maintains that the claims are without merit but is filing supplemental disclosures ahead of the special stockholder meeting scheduled for November 24, 2026.
Tempest Therapeutics filed its Q3 2026 10-Q reporting 19,995,358 shares of common stock outstanding as of November 13, 2026. The company is focused on advancing its clinical-stage programs, including TPST-4003 and TPST-2003, while addressing substantial risks regarding its ability to continue as a going concern and maintain Nasdaq listing compliance.
CareTrust REIT entered into forward sale agreements for 19,550,000 shares of common stock at an initial forward price of $36.00 per share. The transaction includes an initial 17,000,000 shares and the full exercise of an underwriters' option for an additional 2,550,000 shares. The company intends to physically settle the agreements for cash proceeds by November 12, 2027, to fund future acquisitions and for general corporate purposes.
Value
$704M
Counterparty
BofA Securities, Inc. and Morgan Stanley & Co. LLC
RTB Digital, Inc. reported a significant revenue increase to $6.29 million for the nine months ended September 30, 2026, compared to $1.44 million in the prior year, driven by expansion and acquisitions. However, the company incurred a net loss of $19.44 million during this period, primarily due to a sharp rise in general and administrative expenses and losses on the sale of crypto assets.
Mangoceuticals amended its Series B and Series C preferred stock designations and established a new Series D Preferred Stock class. The Series D Preferred Stock will rank senior to common stock and existing preferred classes regarding dividends and liquidation, though no shares were issued at the time of filing. The amendments include waivers from existing preferred holders to allow for the senior ranking and future Series D transactions.
CISO Global reported total revenue of $17.6 million for the nine months ended September 30, 2026, a decrease from $20.3 million in the prior year period. The company reported a net loss of $6.3 million for the first nine months of 2026 and expressed substantial doubt about its ability to continue as a going concern.
GBank Financial Holdings Inc. reported on its financial condition for the quarter ended September 30, 2026, highlighting risks related to credit quality, inflationary pressures, and cybersecurity. As of November 13, 2026, the company had 14,571,526 shares of common stock outstanding and is classified as an emerging growth company.